Insider Buying: Retractable Technologies, Inc. (NYSE:RVP) CEO Purchases 15,363 Shares of Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw acquired 15,363 shares of the business’s stock in a transaction that occurred on Wednesday, April 17th. The shares were purchased at an average cost of $1.03 per share, for a total transaction of $15,823.89. Following the acquisition, the chief executive officer now owns 14,352,831 shares in the company, valued at $14,783,415.93. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Retractable Technologies Stock Performance

NYSE RVP opened at $1.06 on Friday. Retractable Technologies, Inc. has a twelve month low of $0.95 and a twelve month high of $1.87. The business’s fifty day moving average is $1.20 and its 200 day moving average is $1.16. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.28 and a quick ratio of 6.41.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on Retractable Technologies in a report on Wednesday. They set a “hold” rating on the stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of RVP. Vanguard Group Inc. lifted its holdings in Retractable Technologies by 12.6% during the 1st quarter. Vanguard Group Inc. now owns 1,092,079 shares of the company’s stock worth $5,188,000 after buying an additional 122,231 shares during the period. NewEdge Advisors LLC acquired a new position in Retractable Technologies during the 1st quarter worth about $77,000. State Street Corp lifted its holdings in Retractable Technologies by 1.2% during the 1st quarter. State Street Corp now owns 304,431 shares of the company’s stock worth $1,446,000 after buying an additional 3,730 shares during the period. Royal Bank of Canada lifted its holdings in Retractable Technologies by 29.7% during the 1st quarter. Royal Bank of Canada now owns 13,265 shares of the company’s stock worth $63,000 after buying an additional 3,037 shares during the period. Finally, FMR LLC lifted its holdings in Retractable Technologies by 190.0% during the 2nd quarter. FMR LLC now owns 16,216 shares of the company’s stock worth $62,000 after buying an additional 10,625 shares during the period. 7.58% of the stock is owned by institutional investors and hedge funds.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.